AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1

AstraZeneca is powering modern #machinelearning (ML) and AI to accelerate drug discovery with Cambridge-1, training models to learn the grammar of chemistry, and processing whole slide digital pathology images. Learn more about #healthcare and life sciences research on NVIDIA Cambridge-1:
Back to Top